PCA
RCKT icon

Private Capital Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Private Capital Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-85,250
Closed -$3.86M – 108
2015
Q4 		$3.86M Buy
85,250
+12,000
+16% +$523K 1.67% 22
2015
Q3 		$2.75M Buy
+73,250
New +$3.36M 1.15% 39

Other funds holding RCKT

DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Private Capital Advisors's RCKT Position: Q1 2016 in Review

Private Capital Advisors sold out of Rocket Pharmaceuticals (RCKT) in Q1 2016, closing a stake of 85,250 shares — an estimated $3.86M sold.

Private Capital Advisors first reported a position in RCKT in Q3 2015 and held it in 2 quarters. The position peaked at $3.86M in Q4 2015. 58 funds tracked by Wall St. Rank hold RCKT as of Q1 2016.

  • Private Capital Advisors reported no remaining Rocket Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Private Capital Advisors sold 85,250 Rocket Pharmaceuticals shares in Q1 2016, an estimated $3.86M.
  • Private Capital Advisors first reported a position in Rocket Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Private Capital Advisors's Rocket Pharmaceuticals position peaked at $3.86M in Q4 2015.
  • 58 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2016.

Based on Private Capital Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.